Press release archives - Biotechnology

Subscribe to India PRwire Breaking News RSS Feed to instantly access 25 most recent press releases across our network. If you are only interested in Biotechnology industry press releases, subscribe to our Biotechnology RSS feed.

Friday, 29th Jul 2011

Aanjaneya Lifecare Is seriously looking to acquire a brand in cough cold, pain management segment

Aanjaneya Lifecare is looking to acquire a brand or distribution assets within india or abroad to expand our branded formulations business More...

  • Published on Jul 29, 11

Saturday, 16th Jul 2011

Stem Cell Research - An Exclusive Market Insight Report from RI Technologies

RI Technologies Publishes premier source of market research reports, industry reviews, newsletters and conferences for competitive business intelligence needs on the Biotechnology & Healthcare sector. More...

  • Published on Jul 16, 11

Saturday, 11th Jun 2011

Monsanto and Farming Communities join hands to bring down child labour in cotton seed production fields from 20% in 2004 to 0.5% in 2011

25 villages recognized as "Child Labour Free" model villages - 14 in Andhra Pradesh, 7 in Gujarat and 4 in Karnataka More...

  • Published on Jun 11, 11
NSTC launches Nanotechnology Training Programs

Nano Science and Technology Consortium (NSTC) , INDIA announces the Nanotechnology Training (Certification) Programs for different fields of Science & Technology. With the availability of these kind of training programs in India, NSTC is looking forward to sensitize students, professionals and industries with requisite knowledge of Nanotechnology. More...

  • Published on Jun 11, 11

Wednesday, 8th Jun 2011

Apticraft Systems Announces Legal Name Change to PREMIER Biosoft.

Apticraft Systems Pvt. Ltd. announced today the completion of its legal name change to "PREMIER Biosoft India Pvt. Ltd", aligning the corporate strategy with its associate enterprise, PREMIER Biosoft International. More...

  • Published on Jun 8, 11

Monday, 6th Jun 2011

Bharat Biotech announces the price of "ROTAVAC" its potential vaccine against Rotavirus Diarrhoea

ROTAVACĀ® expecting India licensure during 2014,will be sold to global public markets at a price of US $ 1.0 More...

  • Published on Jun 6, 11

Sunday, 5th Jun 2011

Panacea Biotec vows to protect millions of infants across the world from five infectious diseases

Alliance with GAVI to reduce cost of its Pentavalent Vaccine - EasyFive More...

  • Published on Jun 5, 11

Wednesday, 27th Apr 2011

P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug

P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead compounds, PD2005 and PD2007, have received U.S. and Canadian patent protection for treating Attention Deficit/Hyperactivity Disorder (ADHD). More...

  • Published on Apr 27, 11

Wednesday, 13th Apr 2011

P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing

P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder (ADHD) stimulant drug, PD2005, demonstrated efficacy in treating the core symptoms of ADHD in preclinical ADHD models. More...

  • Published on Apr 13, 11

Thursday, 3rd Mar 2011

Panacea Biotec Signs agreement with Laboratorios Clausen S.A

Panacea Biotec Limited, India's 3rd largest biotech company has signed a non-exclusive marketing agreement with Laboratorios Clausen S.A, Uruguay. The agreement will give an access to Laboratorios Clausen S.A to market Panacea Biotec Limited's "Tacrolimus" (Pangraf) in few markets in Europe. More...

  • Published on Mar 3, 11

Tuesday, 15th Feb 2011

Kibow Biotech Founder is an Invited Speaker at the The 6th Nutra India Summit at the World Trade Centre, Mumbai.

Kibow Biotech, Inc., a US-based biotech firm that manufactures a probiotic nutraceutical supplement for patients with kidney failure, is pleased to announced that Dr. Ranganathan, VP (R&D) and interim CEO, has been invited to be a Speaker at The 6th Nutra India Summit. More...

  • Published on Feb 15, 11

Wednesday, 9th Feb 2011

Panacea Biotec Launches - PacliALL A Cost Effective and Novel drug delivery product for Breast Cancer

Panacea Biotec, India's 3rd largest biotechnology company is planning to introduce during Indian Cancer Congress 2011 at Bhubaneswar on 12th Feb 2011; their indigenously developed Albumin bound Paclitaxel particles formulation - PacliALL. More...

  • Published on Feb 9, 11

Friday, 4th Feb 2011

Clot-Busting Drug THR-100 (Staphylokinase) Enters Phase III Clinical Trials in India

Thrombolytic Agent for Treatment of Myocardial Infarction Being Developed for Emerging Markets by Bharat Biotech More...

  • Published on Feb 4, 11

Tuesday, 1st Feb 2011

Vibha Seeds Group CMD Vidyasagar Parchuri was awarded with the "Outstanding AgBio Leadership Award 2011"

Vibha Seeds Group is pleased to announce that its CMD, Vidyasagar Parchuri, has been awarded with the "Outstanding AgBio Leadership Award" at AgBio Global Summit 2011 at Tamil Nadu Agricultural University (TNAU), Coimbatore on January 31, 2011. More...

  • Published on Feb 1, 11

Friday, 28th Jan 2011

Clinical Trials Data Management Course Through BII

With the globalization of the pharmaceutical industry, increased use of medicines and public awareness of safety issues have come forth with the challenges in four areas of operations. More...

  • Published on Jan 28, 11